Walgreens Agrees To $100 Million Settlement Over Alleged Deceptive Pricing Of Generic Drugs

In 2018, the International Brotherhood of Electrical Workers Local 38 Health and Welfare Fund and some consumers filed a proposed class action lawsuit against Walgreens Boots Alliance Inc (NASDAQ:WBA).

The plaintiffs alleged that the retail pharmacy engaged in deceptive pricing practices through its Prescription Savings Club (PSC)—a program offering discounted prices on generic drugs for customers who pay without insurance.

Also Read: Walgreens Boots Alliance Analysts Expect Strategic Plans Will Boost Investor Confidence In 2025

Plaintiffs claim these practices led Walgreens to inflate the “usual and ...